SEPTEMBER 23, 2015

Davis Polk and Goodwin Procter help out on Penumbra's $138 million IPO

Davis, Polk & Wardwell provided counsel to Alameda-based Penumbra Inc. in raising roughly $138 million in its initial public offering, The medical device company sold 4,600,000 shares of common stock at $30 per share. The IPO closed on September 23. The company sells a variety of products for neurosurgery and peripheral vascular disease, a narrowing of arteries that do not lead to the heart or brain.